Annie Fang - Concepedia

Author

Annie Fang

Pfizer (United States)

Also Known As

A. F. Fang, A. Fang, A.F. Fang, Annie F. Fang, Annie Fang

Publications

573

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)University of Miami Arkansas Children's Hospital University of Washington University of California, Davis

About

Annie Fang is an author at Pfizer (United States) specializing in antimicrobial pharmacokinetics, antibiotics, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	48
2	Pharmacology	3	3	48
3	Antibiotics	3	3	48
4	Gastroenterology	1	1	12
5	Antimicrobial Pharmacodynamics	1	1	19

Annie Fang

Publications

515

Citations

H-Index

Page 1

	Year	Citations
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B Adam Cuker, Kaan Kavaklı, Laurent Frenzel, New England Journal of Medicine	2024	66
Bronchopulmonary Disposition of Intravenous Voriconazole and Anidulafungin Given in Combination to Healthy Adults Jared L. Crandon, Mary Anné Banevicius, Annie Fang, Antimicrobial Agents and Chemotherapy	2009	48
Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin Marco Lucchi, Bharat Damle, Annie Fang, Journal of Antimicrobial Chemotherapy	2008	47
Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co‐administered in healthy female subjects Emma Andrews, Bharat Damle, Annie Fang, British Journal of Clinical Pharmacology	2008	44
Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment Hans-Jürgen Stellbrink, Eric Le Fevre, Andrew Carr, AIDS	2016	38
Significant Decrease in Nelfinavir Systemic Exposure After Omeprazole Coadministration in Healthy Subjects Annie Fang, Bharat Damle, Robert R. LaBadie, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2007	37
Giroctocogene fitelparvovec gene therapy for severe hemophilia A: 104-week analysis of the phase 1/2 Alta study Andrew D. Leavitt, Barbara A. Konkle, Kimo C. Stine, Blood	2023	30
Comparative Pharmacokinetics of Voriconazole Administered Orally as either Crushed or Whole Tablets Elizabeth S. Dodds Ashley, Aimee K. Zaas, Annie Fang, Antimicrobial Agents and Chemotherapy	2006	26
Metabolism and Disposition of a Selective α7 Nicotinic Acetylcholine Receptor Agonist in Humans Christopher L. Shaffer, Mithat Gunduz, Renato J. Scialis, Drug Metabolism and Disposition	2007	25
Updated Follow-up of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (SB-525) Gene Therapy in Adults with Severe Hemophilia a Andrew D. Leavitt, Barbara A. Konkle, Kimo C. Stine, Blood	2020	23

Page 1